Zambia wants to track every medicine pack from factory to patient 🇿🇲💊

Cliquez ici pour lire en français

Zambia’s government launched a new scheme on November 2, 2026, aimed at curbing the theft and diversion of medicines from public health facilities. Announced by Health Minister Roma Chilengi, the initiative is being run by the Ministry of Health and the Zambia Medicines Regulatory Authority (ZAMRA). Every box of medicine will get a unique barcode and serial number, so it can be tracked from manufacture or import all the way to the patient.

A labelling system will also separate products meant for public facilities from those sold in private pharmacies. The aim: tighter control over how medicines circulate, and an easier way to spot those that may be sold illegally.

Separate markings for public and private medicines 🏷️

Every medicine box will now have to carry a unique barcode and serial number. Together, they will document its journey through the supply chain, from origin to the moment it is dispensed to a patient. The scheme also introduces two colors of security labels.

Medicines for public facilities will carry a red label reading “Property of the Ministry of Health, Not for Sale.” Those for private pharmacies will get a blue one.

According to the government, the split is meant to help authorities and the public more easily spot state-owned products offered for sale outside authorized channels.

A transition period until April 2027 📅

The official launch took place on November 2, 2026, but industry players have several months to comply. The transition period ends on April 30, 2027 and covers manufacturers, importers, distributors and retailers.

From May 1, 2027, no medicine without a valid security label will be allowed on the Zambian market. The deadline is meant to give everyone time to adjust before the rules apply in full.

Diversion that weakens public health facilities 🚨

The scheme follows several reports of state-supplied medicines and medical supplies turning up in private pharmacies and informal markets. These cases feed concerns about shortages in public health facilities.

They also erode public trust in the health system, especially when products meant for patients in public facilities end up in unauthorized sales channels. By making medicines easier to identify and trace, authorities hope to limit diversion and shrink the room for illegal resale.

Tightening the pharmaceutical supply chain 🛡️

Beyond protecting public stocks, the mechanism aims to lower the risk of stolen, counterfeit or diverted medicines entering legal distribution channels.

Whether it works will depend on coordination between the Ministry of Health and the professionals involved, and on compliance by everyone in the chain. Inspections will have to verify that products on the market meet the new requirements.

With this initiative, Zambia aims to make its pharmaceutical sector more transparent and hold the different players more accountable, while protecting medicines meant for patients.

Can digital medicine-tracking systems really curb diversion and illegal sales across Africa? Tell us what you think in the comments.